小隐静脉再热消融的成功率及再通预测因素
本研究回顾性分析2012至2018年2566例因小隐静脉功能不全行热消融的病例,其中91例因再通行再次消融。再次消融初期技术成功率为98.9%,早期闭合率96.7%,平均随访24.9个月闭合率96.5%,且成功闭合与年龄、性别、CEAP分级、侧别、消融方式、BMI或静脉直径无关。
要点
- 再次热消融治疗再通的小隐静脉闭合率与初次手术相当。
- 再次消融初期技术成功率达98.9%,平均随访24.9个月闭合率96.5%。
- 年龄、性别、CEAP分级、消融方式、BMI及静脉直径与再通无关。
核心结论
- 小隐静脉初次与再次热消融的闭合率相当,再次消融具有潜在应用价值。
研究设计与样本
- 回顾性分析2012至2018年1752例患者共2566例次因小隐静脉功能不全行热消融的病例,其中91例次再次消融。
主要发现
- 再次消融的91例次中,初期技术成功率为98.9%,早期闭合率为96.7%。
- 平均随访24.9±14.9个月,闭合率为96.5%。
- 成功闭合与年龄、性别、CEAP分级、侧别、EVLA与RFA选择、BMI或静脉直径均无相关性。
关键数值与推荐
- 成功闭合定义为术后双功超声无彩色血流。
- 再通定义为随访期间靶血管双功超声显示反流。
- 再次消融靶静脉平均最大直径为4.51±1.33 mm。
临床怎么用
- 对再通的有症状小隐静脉可考虑再次热消融,预期闭合率与初次手术相当。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endothermal ablation, such as endovenous laser ablation (EVLA) and radiofrequency ablation (RFA), has been increasingly used for treatment of small saphenous vein (SSV) insufficiency. Prior studies have shown recurrence rates of 0% to 10% in incompetent SSVs (ISSVs). The objective of the present study was to determine the efficacy of redo venous ablation for symptomatic recanalized SSVs and to predict the factors related to recanalization. METHODS: A retrospective analysis of 2566 procedures in 1752 patients with chronic venous insufficiency due to ISSVs from 2012 to 2018 was performed, using individual medical record review for data extraction. All 2566 procedures were performed using endothermal ablation for patients in whom initial conservative management had failed. Postoperative duplex ultrasound scans were performed within 3 to 7 days after treatment. We defined successful obliteration as a lack of color flow using postoperative duplex ultrasound. We defined recanalization as the presence of reflux on duplex ultrasound in the target vessel during follow-up. We conducted follow-up examinations every 3 months during the first year and every 6 months subsequently. RESULTS: Of the 2566 procedures, redo ablation was performed in 91 ISSVs for 86 patients, including 58 women and 28 men. Of the 91 procedures, 54 were performed on the left lower extremity and 37 on the right lower extremity. The mean body mass index was 32.2 ± 7.66 kg/m2. The mean age was 62.4 ± 15.10 years. The CEAP (Clinical, Etiology, Anatomy, and Pathophysiology) class was C1, C2, C3, C4, C5, and C6 for 0, 0, 29, 43, 1, and 18 patients, respectively. The mean maximum diameter of the targeted veins for the redo procedures was 4.51 ± 1.33 mm. Of the 91 procedures, 40 were performed using EVLA and 51 were performed using RFA. The initial technical success was 98.9%. The redo procedures showed an early closure of 96.7%. At a mean follow-up duration of 24.9 ± 14.9 months, the closure rate was 96.5%. No correlation was found between successful obliteration with the redo procedure and age, gender, CEAP class, laterality, EVLA vs RFA, body mass index, or vein diameter. CONCLUSIONS: The rates of successful closure for ISSVs with initial and redo procedures were comparable. These data have validated the potential usefulness of performing redo SSV ablation.
引用
- Kibrik P, Chait J, Arustamyan M, et al. Success rate and factors predictive of redo endothermal ablation of small saphenous veins. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 34715387. doi:10.1016/j.jvsv.2021.09.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。